Relay Therapeutics, Inc. (RLAY)
USD 4.2
(-6.67%)
USD 4.2
(-6.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -300.31 Million | -229.49 Million | -74.4 Million | -102.48 Million | -66.13 Million | -44.13 Million |
| Net Income | -341.97 Million | -290.5 Million | -363.87 Million | -52.41 Million | -75.3 Million | -48.78 Million |
| Depreciation & Amortization | 5.26 Million | 4.13 Million | 3.92 Million | 3.54 Million | 2.84 Million | 2.15 Million |
| Deferred income taxes | -10.76 Million | - | 2.05 Million | - | - | - |
| Stock-based compensation | 86.03 Million | 56.13 Million | 48.45 Million | 31.96 Million | 4.45 Million | 2.88 Million |
| Change in working capital | -32.45 Million | 11.24 Million | 97.34 Million | -85.17 Million | 4.31 Million | -400 Thousand |
| Other non-cash items | -6.42 Million | -10.49 Million | 137.69 Million | -416 Thousand | -2.43 Million | 9000.00 |
| Investing Cash Flow | 257.63 Million | -188.74 Million | -479.51 Million | 81.67 Million | -319.02 Million | -1.68 Million |
| Investments in PPE | -4.12 Million | -9.06 Million | -3.47 Million | -1.93 Million | -8 Million | -1.68 Million |
| Acquisitions | -257.63 Million | 179.68 Million | -25.29 Million | -83.6 Million | 20 Thousand | 7000.00 |
| Investment purchases | -385.54 Million | -535.41 Million | -980.66 Million | -266.45 Million | -553.51 Million | - |
| Sales/Maturities of investments | 647.3 Million | 355.73 Million | 529.92 Million | 350.05 Million | 242.47 Million | - |
| Other Investing Activities | 257.63 Million | -179.68 Million | -450.74 Million | 83.6 Million | -311.02 Million | 7000.00 |
| Financing Cash Flow | 34.75 Million | 289.91 Million | 388.09 Million | 426.5 Million | 5.6 Million | 394.97 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -82 Thousand |
| Common Stock Issuance | 30.28 Million | 284.74 Million | 382.21 Million | 427.8 Million | 613 Thousand | 799 Thousand |
| Other Financing Activities | 4.47 Million | 5.16 Million | 5.88 Million | -1.29 Million | 4.99 Million | 394.97 Million |
| Accounts receivables | 306 Thousand | 97 Thousand | 74.67 Million | -75 Million | - | - |
| Accounts payables | -2.39 Million | 1.98 Million | 930 Thousand | -410 Thousand | 3 Million | 1.23 Million |
| Inventory | -31.87 Million | - | 21.46 Million | -10.33 Million | - | - |
| Other working capital | 1.5 Million | 9.16 Million | 277 Thousand | 571 Thousand | 1.31 Million | -1.63 Million |
| Cash at beginning of period | 154.37 Million | 282.69 Million | 448.52 Million | 42.83 Million | 422.38 Million | 73.22 Million |
| Cash at end of period | 146.44 Million | 154.37 Million | 282.69 Million | 448.52 Million | 42.83 Million | 422.38 Million |
| Capital Expenditure | -4.12 Million | -9.06 Million | -3.47 Million | -1.93 Million | -8 Million | -1.68 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.92 Million | -128.32 Million | -165.82 Million | 405.69 Million | -379.55 Million | 349.15 Million |
| Free Cash Flow | -304.44 Million | -238.55 Million | -77.87 Million | -104.42 Million | -74.13 Million | -45.82 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -92.21 Million | -81.38 Million | -83.49 Million | -341.97 Million | -65.73 Million | -98.5 Million |
| Depreciation & Amortization | 1.36 Million | 1.39 Million | 1.37 Million | 5.26 Million | 1.36 Million | 1.33 Million |
| Deferred income taxes | - | - | 5.07 Million | -10.76 Million | -2.87 Million | -2.2 Million |
| Stock-based compensation | 26.83 Million | 27.18 Million | 19.26 Million | 86.03 Million | 21.83 Million | 23.41 Million |
| Change in working capital | 12.84 Million | 7.97 Million | -20.59 Million | -32.45 Million | -28.78 Million | 9.51 Million |
| Other non-cash items | 11.69 Million | 24.37 Million | -10.81 Million | -6.42 Million | -1.2 Million | -2.15 Million |
| Investing Cash Flow | 45.55 Million | 10.53 Million | 59.67 Million | 257.63 Million | 71.36 Million | 51.27 Million |
| Investments in PPE | -11 Thousand | -1.78 Million | -118 Thousand | -4.12 Million | -590 Thousand | -1.5 Million |
| Acquisitions | - | - | -257.63 Million | -257.63 Million | -71.95 Million | -52.78 Million |
| Investment purchases | -119.63 Million | -190.78 Million | -136.81 Million | -385.54 Million | -84.75 Million | -66.16 Million |
| Sales/Maturities of investments | 165.19 Million | 203.09 Million | 196.61 Million | 647.3 Million | 156.7 Million | 118.94 Million |
| Other Investing Activities | 45.56 Million | 12.31 Million | 257.63 Million | 257.63 Million | 71.95 Million | 52.78 Million |
| Financing Cash Flow | 1.54 Million | 48.92 Million | 21.91 Million | 34.75 Million | 9.45 Million | 2.08 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.54 Million | 48.92 Million | 20.91 Million | 30.28 Million | 9.45 Million | 2.08 Million |
| Other Financing Activities | 1.54 Million | 48.92 Million | 1 Million | 4.47 Million | 9.45 Million | 2.08 Million |
| Accounts receivables | - | - | 211 Thousand | 306 Thousand | -133 Thousand | 208 Thousand |
| Accounts payables | 3.2 Million | 102 Thousand | -5.37 Million | -2.39 Million | -1.22 Million | 2.8 Million |
| Inventory | - | - | 21.69 Million | -31.87 Million | -27.78 Million | 6.09 Million |
| Other working capital | 9.63 Million | 7.87 Million | -37.13 Million | 1.5 Million | 359 Thousand | 409 Thousand |
| Cash at beginning of period | 152.86 Million | 143.73 Million | 154.03 Million | 154.37 Million | 148.6 Million | 163.85 Million |
| Cash at end of period | 134.12 Million | 152.86 Million | 146.44 Million | 146.44 Million | 154.03 Million | 148.6 Million |
| Capital Expenditure | -11 Thousand | -1.78 Million | -118 Thousand | -4.12 Million | -590 Thousand | -1.5 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -18.74 Million | 9.13 Million | -7.59 Million | -7.92 Million | 5.42 Million | -15.24 Million |
| Free Cash Flow | -65.84 Million | -52.1 Million | -89.3 Million | -304.44 Million | -75.98 Million | -70.1 Million |
BFISH
AUTME
POR
STRR
393890
AFH